CD226 and viral infectious disease: Furthermore, in view of the widely reported involvement of ligands for DNAM-1 in the immune response against cells infected with different types of viruses (2), including SARS-CoV-2 (13), these data suggest to extend the exploration of the use of DNAM-1-engineered NK cells in the context of viral infection.